Revenue | ₹225.68Cr |
Net Profits | ₹23.80Cr |
Net Profit Margins | 10.55% |
Bliss GVS Pharma Ltd’s revenue jumped 9.48% since last year same period to ₹225.68Cr in the Q3 2024-2025. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated 1.33% jump in its revenue since last 3-months.
Bliss GVS Pharma Ltd’s net profit fell -13.8% since last year same period to ₹23.80Cr in the Q3 2024-2025. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated -1.9% fall in its net profits since last 3-months.
Bliss GVS Pharma Ltd’s net profit margin fell -21.26% since last year same period to 10.55% in the Q3 2024-2025. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated -3.18% fall in its net profit margins since last 3-months.
The revenue for Bliss GVS Pharma Ltd in the Q3 results 2024 was ₹225.68Cr.
The net profit for Bliss GVS Pharma Ltd in the Q3 results 2024 was ₹23.80Cr.
The net profit margin for Bliss GVS Pharma Ltd in the Q3 results 2024 was 10.55%.
The revenue for Bliss GVS Pharma Ltd in the Q3 results 2023 was ₹206.14Cr.
The net profit for Bliss GVS Pharma Ltd in the Q3 results 2023 was ₹27.61Cr.
The net profit margin for Bliss GVS Pharma Ltd in the Q3 results 2023 was 13.39%.